Session 4: FDA Drug Review
The structural similarities between the FDA's drug reviews and many other regulatory bodies' judgments include high uncertainty, low reversibility, avoiding observable error, and high political stakes that encourage lobbying by interested parties. This essay investigates the policy implications of considering FDA drug evaluation as a politically motivated information processing activity. I contend that the incentives regulators face place restrictions on how quickly medication reviews may be completed, that these motivations may make privatization efforts difficult, and that political pressures may be helpful in identifying high-priority pharmaceuticals.
·Pharmaceuticals
·Disease
·Politics
·HIV\ AIDS
·Prescription Drug Costs
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
